Gemcitabine-associated Sweet syndrome–like eruption Antonio Martorell-Calatayud, MD, Celia Requena, MD, PhD, Onofre Sanmartin, MD, PhD, Nicole Balmer, MD, Carlos Guillen-Barona, MD, PhD Journal of the American Academy of Dermatology Volume 65, Issue 6, Pages 1236-1238 (December 2011) DOI: 10.1016/j.jaad.2009.04.003 Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 A-C, Erythematous plaques on the upper trunk and both arms 7 days after gemcitabine infusion. D, Details of the pseudovesicular plaques on the trunk. Journal of the American Academy of Dermatology 2011 65, 1236-1238DOI: (10.1016/j.jaad.2009.04.003) Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 A and B, Perivascular and interstitial dermatitis in the papillary and superficial dermis. C, Neutrophils predominate in the inflammatory infiltrate. D, Nuclear dust between inflammatory cells. There is no evidence of vasculitis. (Hematoxylin–eosin stain; original magnification: A, ×25; B, ×50; C, ×100; D, ×200.) Journal of the American Academy of Dermatology 2011 65, 1236-1238DOI: (10.1016/j.jaad.2009.04.003) Copyright © 2009 American Academy of Dermatology, Inc. Terms and Conditions